Nonparametric population pharmacokinetic model of Amikacin in respiratory critical ill patients

被引：0
|
作者：
Riff, C. [1 ]
Woillard, J. B. [1 ]
Hraiech, S. [2 ]
Woloch, C. [1 ]
Marsot, A. [3 ]
Guilhaumou, R. [3 ]
Blin, O. [3 ]
Saint-Marcoux, F. [1 ]
机构：
[1] CHU Limoges, Lab Pharmacol Toxicol & Pharmacovigilance, Limoges, France
[2] Hop Nord Marseille, Serv Reanimat Med Detresses Resp, Infect Severes, Marseille, France
[3] Aix Marseille Univ, AMU CNRS 7289, Serv Pharmacol Clin & Pharmacovigilance, Inst Neurosci Timone,AP HM,Pharmacol Integree & I, Marseille, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2016年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
CO-059
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies
    Marsot, Amelie
    Guilhaumou, Romain
    Riff, Camille
    Blin, Olivier
    CLINICAL PHARMACOKINETICS, 2017, 56 (02) : 127 - 138
  • [2] Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies
    Amélie Marsot
    Romain Guilhaumou
    Camille Riff
    Olivier Blin
    Clinical Pharmacokinetics, 2017, 56 : 127 - 138
  • [3] Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants, and children
    Tréluyer, JM
    Merlé, Y
    Tonnelier, S
    Rey, E
    Pons, G
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1381 - 1387
  • [4] Amikacin loading dose in critically ill patients: development of a non-parametric population pharmacokinetic model
    Boidin, C.
    Bourguignon, L.
    Cohen, S.
    Roger, C.
    Lefrant, J. Y.
    Roberts, J. A.
    Allaouchiche, B.
    Lepape, A.
    Friggeri, A.
    Goutelle, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 : 24 - 24
  • [5] Nonparametric population analysis of amikacin pharmacokinetic pediatric data.
    Merle, Y
    Treluyer, J
    Tonnelier, S
    Rey, E
    Pons, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P77 - P77
  • [6] Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients
    del Mar Fernandez de Gatta, Maria
    Romano Moreno, Silvia
    Victoria Calvo, Maria
    Ardanuy, Ramon
    Dominguez-Gil, Alfonso
    Lanao, Jose M.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2009, 61 (06) : 759 - 766
  • [7] Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize A Priori Pharmacokinetic/Pharmacodynamic Target Attainments in Individual Patients
    Boidin, Clement
    Bourguignon, Laurent
    Cohen, Sabine
    Roger, Claire
    Lefrant, Jean-Yves
    Roberts, Jason A.
    Allaouchiche, Bernard
    Lepape, Alain
    Friggeri, Arnaud
    Goutelle, Sylvain
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (11)
  • [8] Population pharmacokinetics of amikacin in critically ill patients
    Bressolle, F
    Gouby, A
    Martinez, JM
    Joubert, P
    Saissi, G
    Guillaud, R
    Gomeni, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) : 1682 - 1689
  • [9] Population pharmacokinetic/pharmacodynamic evaluations of amikacin dosing in critically ill patients undergoing continuous venovenous hemodiafiltration
    Li, Sanwang
    Zhu, Sucui
    Xie, Feifan
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2023, 75 (04) : 515 - 522
  • [10] Amikacin Population Pharmacokinetics in Critically Ill Kuwaiti Patients
    Matar, Kamal M.
    Al-lanqawi, Yousef
    Abdul-Malek, Kefaya
    Jelliffe, Roger
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
12345